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Summary: Small numbers of Cryptosporidium parvum 
oocysts can remain behind and contaminate even treated 
drinking water, making it an important source of human 
infection. Ingestion of oocysts can cause diarrheal dis­
ease in normal as well as immunocompromised hosts, 
with a tendency to protracted diarrhea in the latter.
Aims, subjects, and methods: To determine the infectious 
dose of C. parvum, 29 healthy adults (students and ad­
ministrative and research staff members of the Texas 
Medical Center), after being given ample information, 
volunteered to become infected with oocysts. Subjects 
were informed that the organism could spread to house­
hold contacts. Subjects were excluded if their households 
included an infant, an elderly person, or someone who 
was chronically ill. Household contacts were also in­
formed of the study. All participants were in good health 
and had normal immune status. Furthermore, they were 
required to not be pregnant and to be tuberculin-negative 
and negative for C. parvum on enzyme-linked immuno­
sorbent assay (ELISA). The organism used was originally 
isolated from a calf in Iowa and subsequently propagated 
in 1-day-old calves at the University of Arizona. From 
their feces, oocysts were isolated, purified, stored, 
cooled, and shipped overnight to Texas.
Diverse culturing of inoculums was done to exclude the 
presence of viral, phagelike, and bacterial agents. Viabil­
ity was tested comparing in vitro excystation in corre­
sponding batches of inoculums, before and after ship­
ment. Infectivity of oocysts was confirmed in laboratory 
mice with an initial dose of 60 oocysts per mouse, as 
previously described (Appl Environ Microbiol 1990;56: 
1423-8). After careful assessment of the number of 
oocysts in each lot, dilutions were performed to obtain 
concentrations ranging from 30 to one million, which 
were placed in gelatin capsules.
Within 1 h of preparation, capsules and 250 ml of buff­
ered saline were given to the subjects, while no food or 
drink was allowed for 90 min before and after ingestion of 
the capsule. The subjects’ household contacts were mon­
itored weekly. All stools passed were collected for 2 
weeks and thereafter 2 days per week for 2 months. De­
tails of diarrheal disease in the subjects and their contacts 
were obtained. In cases of diarrhea, stools were also ex­
amined for conventional pathogens apart from C. par­
vum. Cryptosporidiosis was defined as infection (oocyst- 
positive stools) plus diarrheal illness.
Results. Of 112 volunteers, 19 (17%) were seropositive for 
anticryptosporidial antibody by ELISA. Of the remaining 
93 seronegative volunteers, 29 were finally selected for 
the study. Eighteen (62%) of them developed Cryptospo­
ridium infection, within the whole range (30 to one mil­
lion) of dose levels. Linear regression analysis yielded a 
mean infective dose (ID50) of 132 oocysts of C. parvumf 
compared with an ID50 of 60 oocysts of the same Iowa 
strain in neonatal mice. None of the 10 uninfected sub­
jects (one being excluded from the study because of non- 
challenge-related enteric symptoms) had sy mptoms of en­
teric infection. Of the 18 oocyst-excreting subjects, 11 
(61%) did have symptoms, which included fever, nausea, 
vomiting, abdominal pain or cramps, and gas-related in­
testinal symptoms. Seven (39%) also had diarrheal illness 
and were thus considered to have clinical crypto­
sporidiosis.
Illness lasted 58-87 (mean 74) h, with a maximum num­
ber of four to 11 (mean 6.4) unformed stools per day. All 
seven reported abdominal pain and cramps, six had nau­
sea, one reported gas-related symptoms, and one had 
vomiting. The number of ingested oocysts did not sub­
stantially influence the length of the incubation period 
(mean and median 9 and 6.5 days, respectively) nor the 
duration or severity of illness. However, with higher 
doses of oocysts, infection tended to occur sooner and 
last longer. Since the aim of the study was not to outline 
the natural history of experimental cryptosporidiosis, all 
subjects with diarrheal disease received a 5-day course of 
paromomycin. Of 30 household contacts, no secondary 
spread was documented.
Conclusions. In healthy adults with no serologic evidence 
of past infection with C. parvum, a low dose of C. parvum 
oocysts is sufficient to cause infection.
Comment: Since 1976, C. parvum has been recognized as 
a human pathogen, especially in the immunocompro­
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mised host. It has been noted to be an important public 
health problem in the past decade. By now it is a well- 
established cause of acute diarrhea in different parts of 
the world. This study in volunteers confirms the high in- 
fectivity of Cryptosporidium organisms by means of its 
oocysts, which are known to be resistant to chlorination 
but are killed by high temperatures and freezing. Infec­
tion can be transmitted through person-to-person or ani- 
mal-to-person contact, ingestion of fecally contaminated 
water or food, or contact with fecally contaminated en­
vironmental surfaces. In the U.S.A., 65-97% of surface 
waters contain Cryptosporidium oocysts, and crypto- 
sporidiosis has become a notifiable disease since January
1995 (MMWR 1995 ;44/no.RR-6:1-16).
As demonstrated in the study, only a small number of 
viable oocysts is needed for infection. Illness in a healthy 
individual who has not been in previous contact with the 
parasite is acute, enteric, and self-limiting, lasting 3 days 
on average. However, even in immunocompetent chil­
dren, chronic diarrhea due to proximal intestinal damage 
and followed by spontaneous recovery is known to occur
0Gut 1992;33:1057-61). As in giardiasis, the worldwide 
prevalence of cryptosporidiosis is associated with low 
levels of hygiene and sanitation. For example, in Brazil, 
poor families have high transmission rates and seroposi- 
tivity rates =5100% (Ann Intern Med 1994;120:500-5). In 
poor Latin American children, multiple infections with 
intestinal protozoan and helminthic parasites are common 
and may contribute to the fact that, for example, among 
Brazil’s impoverished families malnutrition prevalences 
in children have doubled between 1974 and 3986 (Lancet 
1994;343:48).
For young children living in the Third World, inocula­
tion with C. parvum is part of a parcel of gastrointestinal 
infections. In less-developed countries prevalences of 
cryptosporidiosis among those who are seeking medical 
care range from 0.5% to 32% (Pediatr Infect Dis 1986;5: 
117-30; J  Trop Pediatr 1993;39:132-6). A study from 
Guinea Bissau (West Africa) shows that cryptosporidiosis
contributes to diarrheal mortality in healthy children <5 
years old (Br Med J  1993;307:417-20). It is not clear 
whether seropositivity protects against reinfection or 
modifies illness. DuPont et al. are presently undertaking 
studies in healthy volunteers to determine the role of pri­
mary infection in inducing immunity. Like infection with 
G. duodenalis, an asymptomatic carrier state or a long­
standing (intermittently) symptomatic state of C. parvum 
infection appears to occur in relatively healthy children 
(Am J  Trop Med Hyg 1993;49:63-7). This finding could 
suggest that at a population level, similar to findings in 
giardiasis (Am J Clin Nutr 1986;43:395^05), a significant 
interaction between chronic Cryptosporidium infection 
and nutrition could play a role in the development of un­
dernutrition. Studies are needed to investigate this issue.
In the presence of a compromised immunity, C. par­
vum infection has a clinically variable course, ranging 
from acute and dehydrating diarrhea to protracted diar­
rhea with a debilitating effect on nutritional status (Gut 
1988;29:593-7). Generally, an effective immune system is 
required to overcome Cryptosporidium infection, and so 
far no drugs have been able to cure cryptosporidiosis in 
the immunocompromised host. Important questions re­
main unanswered: the biology of the parasite is little 
known, and therefore chemotherapy cannot be targeted. 
Furthermore, the role of parasite virulence versus preex­
isting mucosal B-cell immunity needs clarification (Lan­
cet 1995;345:1128-9). Sufficient levels of specific secre­
tory IgA antibodies to Cryptosporidium have been re­
ported not to be able to control infection in AIDS patients 
(J Med Microbiol 1994;40:10-4). At present, with regard 
to Cryptosporidium and its host there are not many an­
swers to be given.
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